Trajan Wealth LLC: AOS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Trajan Wealth LLC on AOS, newest first. How the timeline and the estimate are built.
Trajan Wealth LLC held 0 AOS shares at 2025-12-31 per its 13F-HR filed 2026-02-06.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -2,934 shares
13F-HR 0001934415-26-000001 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 2,934 sharesChange vs previous 13F -244 shares
0.01% of the 13F portfolio, value $215,835.
13F-HR 0001934415-25-000005 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,178 sharesChange vs previous 13F -490 shares
0.01% of the 13F portfolio, value $208,381.
13F-HR 0001934415-25-000004 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,668 sharesChange vs previous 13F +263 shares
0.01% of the 13F portfolio, value $239,740.
13F-HR 0001085146-25-002998 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,405 sharesChange vs previous 13F +332 shares
0.01% of the 13F portfolio, value $232,255.
13F-HR 0001934415-25-000002 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 3,073 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $276,048.
13F-HR 0001934415-24-000006 filed by Trajan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).